A Simple Measure to Assess Hyperinflation and Air Trapping: 1-Forced Expiratory Volume in Three Second / Forced Vital Capacity

Yıl 2017, Cilt: 34 Sayı: 2, 113 - 118, 01.03.2017

Sermin Börekçi Tunçalp Demir Aslı Görek Dilektaşlı Melahat Uygun Nurhayat Yıldırım

https://izlik.org/JA64WN58LE

Anahtar Kelimeler

1-FEV3/FVC , hyperinflation , spirometry

Kaynakça

• 1. Hansen, JE. Clinical Function Testing δ Interpretation. Clinical Focus Series, 1st ed. London, Jaypee Brothers Medical Publishers, 2011.
• 2. Burgel PR, Bourdin A, Chanez P, Chabot F, Chaouat A, Chinet T, at al. Update on the roles of distal airways in COPD. Eur Respir Rev 2011;20:7-22.
• 3. Hansen JE, Sun XG, Wasserman K. Discriminating measures and normal values for expiratory obstruction. Chest 2006;129:369-77.
• 4. Hogg JC, McDonough JE, Sanchez PG, Cooper JD, Coxson HO, Elliott WM, et al. Micro-Computed Tomography Measurements of Peripheral Lung Pathology in Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2009;6:546-9.
• 5. McNulty W, Usmani OS. Techniques of assessing small airways. Eur Clin Respir J 2014;1.
• 6. Morris ZQ, Coz A, Starosta D. An isolated reduction of the FEV3/FVC ratio is an indicator of mild lung injury. Chest 2013;144:1117-23.
• 7. Zelter M. The return of FEV3. Chest 2013;144:1089-91.
• 8. Lam DC, Fong DY, Yu WC, Ko FW, Lau AC, Chan JW, et al. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese. Int J Tuberc Lung Dis 2012;16:681-6.
• 9. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. ATS/ERS Task Force: Standardisation of lung function testing. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948- 68.
• 10. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. ATS/ERS Task Force: Standardisation of lung function testing. General considerations for lung function testing. Eur Respir J 2005;26:153-61.
• 11. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. ATS/ERS Task Force: Standardisation of lung function testing. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
• 12. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. ATS/ERS Task Force: Standardisation of lung function testing. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-22.
• 13. Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105:907-15.
• 14. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(Suppl 5):S1-28.
• 15. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009;180:3-10.
• 16. Hansen JE, Porszasz J, Casaburi R, Stringer WW. Re-defining lower limit of normal for FEV1/FEV6, FEV1/FVC, FEV3/FEV6 and FEV3/FVC to improve detection of airway obstruction. J COPD F 2015;2:94-102.
• 17. Burgel PR. The role of small airways in obstructive airway diseases. Eur Respir Rev 2011;119:23-33.
• 18. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006;27:951-6.
• 19. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-64.
• 20. Miller MR, Grove DM, Pincock AC. Time domain spirogram indices: their variability and reference values in nonsmokers. Am Rev Respir Dis 1985;132:1041-8.
• 21. Miller MR, Pincock AC, Grove DM. Patterns of spirometric abnormality in individual smokers. Am Rev Respir Dis 1985;132:1034-40.
• 22. US Department of Health and Human Services (DHHS) National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988 - 1994: NHANES III Raw Spirometry Data File. Hyattsville, MD: Centers for Disease Control and Prevention; 2001.